The influx of year-end initial public offerings (IPOs) is increasing the supply and demand burden on the domestic stock market. Unlike China, which has halted new listings to defend its market, South Korea has seen over ten companies go public in November alone, absorbing existing liquidity with their subscription deposits.
According to investment banking (IB) sources on November 19, twelve companies, excluding special purpose acquisition companies (SPACs), have either listed or are set to list on KOSDAQ this month. The listings began on November 2 with Youngkwang (offering price 17,000 won), followed by Rebel Up (November 3, 19,000 won) and EST (November 4, 12,400 won). This was followed by Dongwon Parts (November 10, 26,500 won), Baro Farm (November 11, 16,400 won), NexEye (November 12, 8,000 won), Youngkwang YKMC (November 16, 11,000 won), Optonics (November 17, 12,000 won), and AEL Robotics (November 18, 17,600 won), all entering the market within a day or two of each other. With Hana Aerodynamics (5,700 won) joining on November 20, MBIDI (7,000 won) on November 24, and Ucast on November 30, three to four companies are set to list each week.
The issue is that the stock market is showing weakness due to external factors, coinciding with the concentrated listing schedule. Amid the impact of the U.S. midterm elections, prolonged high interest rates, and concerns over a European economic downturn, subscription deposits amounting to trillions of won are being tied up in public offerings. This not only reduces the existing market's buying power but also creates a vicious cycle that dampens the supply and demand for subsequent public offerings.
An IPO industry insider stated, "In the past, large deals temporarily absorbed liquidity, but recently, small to medium-sized deals have been pouring in at short intervals, depleting institutional funds in real time. Even quality companies are unable to receive their fair value due to year-end supply and demand bottlenecks."
China's response stands in stark contrast. Chinese authorities have implemented measures to support the market, including lowering bank interest rates for stock buybacks, expanding swaps, restricting major shareholder sales, and even temporarily halting new IPOs. The goal is to prevent capital outflow from new listings and defend the existing market.
In South Korea, there are calls to adjust the pace of listings, but the industry's structure leads to a repeated concentration of year-end IPOs. A major reason cited is the performance-based compensation system in securities firms' IB departments. Evaluations and bonuses are based on the current year's listing performance, making it advantageous to complete listings within the year, even if it means lowering the offering price. The industry's high turnover also means that contributions from existing deals are often not recognized if they extend into the next year.
The issue of venture capital (VC) fund recoveries and startup funding is also intertwined. Unlike overseas, South Korea lacks an active secondary market for unlisted stocks, so the recovery methods for maturing VC funds are essentially focused on IPOs. Startups, facing difficulties attracting private investment due to high interest rates, are also forced to rely on public offering funds.
Amid these circumstances, the polarization of public offering market success is evident. AEL Robotics and Hana Aerodynamics attracted subscription deposits of 4.4 trillion won and 5.8 trillion won, respectively, while MBIDI, which followed, had a competition ratio of 172 to 1, with only 300 billion won in deposits. MBIDI's institutional demand forecast orders fell short of the desired band (9,600 to 11,700 won) by 76.34%, and there were no commitments to hold shares, yet the offering price was set at 7,000 won, 27% lower than the band’s lower limit.
NexEye, a promising biotech company expected to be valued at over 500 billion won, also lowered its offering price to 8,000 won, below the band’s lower limit, due to poor demand forecasts. JNTG and CNM have even withdrawn their listing plans altogether.
A capital market official remarked, "While IPOs serve a direct financing function, the structure of listing three to four times a week does not help support the existing market. To protect market liquidity and investor sentiment in public offerings, year-end listing schedules need to be spread out, and institutional remedies should be established."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.